StemCells (STEM) Reports In-Line Q4 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. AA
6. RKLB
7. BLK
8. FMC
9. MRSH
10. RSG

Go back to StemCells (STEM) Reports In-Line Q4 EPS

StemCells, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Business Update

March 23, 2016 4:05 PM EDT

NEWARK, Calif., March 23, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ: STEM), a leading stem cell company developing novel cell-based therapeutics for the treatment of serious central nervous system diseases, announced today that it will provide a business update and discuss financial results for the fourth quarter and year ended December 31, 2015, tomorrow, March 24, at 5:00 a.m. Pacific Daylight Time (8:00 a.m. Eastern Daylight Time).

Given our growing clinical data, our recent operational changes and our laser like focus on spinal cord injury, we feel increasingly confident in our ability to execute... More